In Wake of Pilva V. Mensing, an Uproar: FDA’s New Proposed Rule Would Let Generic Drug Makers Update Their Warning Labels |

In 2012, the U.S. Supreme Court ruled in the case of Pilva, Inc. v. Mensing that the makers of generic pharmaceuticals cannot update their warning labels i

FDA Allows Drug Company Representatives to Attend Painkiller Drug Panel | DC Metro Area Medical Malpractice Law Blog

Posted by: Salvatore J. Zambri, founding member and partner   Have drug companies become too close to the organization that is supposed to regulate th

FDA Recall: DePuy Orthopaedics Class I Recall for LPS Diaphyseal Sleeve | DC Metro Area Medical Malpractice Law Blog

Posted by Salvatore J. Zambri, founding member and partner   The FDA recently announced a Class 1 Recall for DePuy Orthopedics.  We are reproduci

Should Compounding Pharmacies Be Required to Follow FDA Safety Regulations? | DC Metro Area Medical Malpractice Law Blog

Posted by Salvatore J. Zambri, founding member and partner   The International Academy of Compounding Pharmacies has traditionally fought against FDA